Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bavencio
Bavencio
ASCO: Merck KGaA, Pfizer's Bavencio combo misses survival mark in crowded kidney cancer space
Fierce Pharma
Thu, 05/23/24 - 09:52 pm
ASCO 2024
Merck KGaA
Bavencio
Pfizer
Inlyta
kidney cancer
clinical tirals
Pfizer donates rights to cancer drug
Beckers Hospital Review
Wed, 12/13/23 - 09:39 am
Pfizer
Bavencio
AACR
cancer
Merck KGaA takes back control of PD-L1 cancer drug as Pfizer alliance ends
Endpoints
Mon, 03/27/23 - 10:04 pm
Merck KGaA
Pfizer
cancer
Bavencio
Merck KGaA pens $855M upfront, biobucks pact with Debiopharm for next-gen cancer asset
Fierce Biotech
Mon, 03/1/21 - 10:32 am
Merck KGaA
Debiopharm
biobucks
Bavencio
Debio1143
xevinapant
ESMO: Pfizer, Merck KGaA's Bavencio comes up short against placebo in risky head and neck cancer trial
Fierce Pharma
Sat, 09/19/20 - 09:20 pm
ESMO
Pfizer
Merck KGaA
Bavencio
head and neck cancer
clinical trials
ASCO: Pfizer, Merck KGaA's Bavencio posts win in rare gynecological cancer
Fierce Pharma
Thu, 05/28/20 - 11:08 pm
Pfizer
Merck KGaA
Bavencio
ASCO 2020
bladder cancer
gestational trophoblastic tumors
clinical trials
Bavencio from Merck KGaA, Pfizer encounters yet another trial setback
Endpoints
Fri, 03/13/20 - 11:15 am
Merck KGaA
Pfizer
Bavencio
clinical trials
head and neck cancer
Merck KGaA, Pfizer's Bavencio set to seal bladder cancer approval after confirmatory trial scores
Endpoints
Mon, 01/6/20 - 10:16 am
Merck KGaA
Pfizer
Bavencio
bladder cancer
FDA
Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial
Marketwatch
Fri, 11/8/19 - 10:45 am
Merck KGaA
Pfizer
Bavencio
clinical trials
gastric cancer
Merck, Pfizer execs explain how they tap sites for cancer trials
Biopharma Dive
Tue, 09/24/19 - 07:04 pm
cancer
clinical trials
Pfizer
Merck
immuno-oncology
Bavencio
Keytruda
Merck and Pfizer’s Bavencio approved for renal cell carcinoma
Pharmaforum
Wed, 05/15/19 - 10:35 am
Merck KGaA
Pfizer
Bavencio
FDA
Inlyta
advanced renal cell carcinoma
Pfizer, Merck KGaA throw in the towel on another Bavencio PhIII as once bright hopes shrivel fast
Endpoints
Tue, 03/19/19 - 08:22 pm
Pfizer
Merck KGaA
ovarian cancer
Bavencio
As Pfizer kills failed PhIII programs for Bavencio, where do they go from here in R&D?
Endpoints
Tue, 01/29/19 - 10:02 am
Pfizer
Bavencio
R&D
Bavencio fails second ovarian cancer Phase III trial
BioCentury
Fri, 12/21/18 - 11:07 pm
Merck KGaA
Bavencio
ovarian cancer
Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK
Fierce Pharma
Thu, 12/20/18 - 10:12 am
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
Pfizer's PARP, androgen inhibitors next combo partners for NKTR-214
BioCentury
Tue, 11/6/18 - 11:35 am
Pfizer
Nektar Therapeutics
NKTR-214
Xtandi
Talzenna
Bavencio
prostate cancer
Pfizer preps for BMS showdown with Bavencio kidney cancer combo data
Fierce Pharma
Sun, 10/21/18 - 11:28 pm
Pfizer
Bristol-Myers Squibb
kidney cancer
Bavencio
Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer
Yahoo/Reuters
Tue, 09/11/18 - 09:28 am
Merck KGaA
Bavencio
Pfizer
kidney cancer
Inlyta
Merck's Keytruda threatens Pfizer, Merck KGaA's Bavencio with Merkel cell 'priority' tag
Fierce Pharma
Tue, 09/4/18 - 11:05 am
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
FDA
How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment
Motley Fool
Thu, 03/15/18 - 09:55 am
cancer
oncology
Pfizer
Ibrance
breast cancer
Xtandi
prostate cancer
Bavencio
bladder cancer
Merkel cell carcinoma
lorlatinib
metastatic non-small cell lung cancer
talazoparib
metastatic breast cancer
Pages
1
2
next ›
last »